His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form
- PMID: 16787919
- DOI: 10.1074/jbc.M605083200
His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form
Abstract
A polymorphism in complement factor H has recently been associated with age-related macular degeneration (AMD), the leading cause of blindness in the elderly. A histidine rather than a tyrosine at residue position 384 in the mature protein increases the risk of AMD. Here, using a recombinant construct, we show that amino acid 384 is adjacent to a heparin-binding site in CCP7 of factor H and demonstrate that the allotypic variants differentially recognize heparin. This functional alteration may affect binding of factor H to polyanionic patterns on host surfaces, potentially influencing complement activation, immune complex clearance, and inflammation in the macula of AMD patients.
Similar articles
-
Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism.J Biol Chem. 2007 Jun 29;282(26):18960-8. doi: 10.1074/jbc.M609636200. Epub 2007 Mar 13. J Biol Chem. 2007. PMID: 17360715
-
Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.J Biol Chem. 2010 Sep 24;285(39):30192-202. doi: 10.1074/jbc.M110.103986. Epub 2010 Jul 26. J Biol Chem. 2010. PMID: 20660596 Free PMC article.
-
The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells.J Biol Chem. 2007 Apr 13;282(15):10894-900. doi: 10.1074/jbc.M610256200. Epub 2007 Feb 9. J Biol Chem. 2007. PMID: 17293598
-
Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology.Biochem Soc Trans. 2010 Oct;38(5):1342-8. doi: 10.1042/BST0381342. Biochem Soc Trans. 2010. PMID: 20863311 Review.
-
Age-related macular degeneration: Complement in action.Immunobiology. 2016 Jun;221(6):733-9. doi: 10.1016/j.imbio.2015.11.007. Epub 2015 Dec 19. Immunobiology. 2016. PMID: 26742632 Review.
Cited by
-
Complement factor H in molecular regulation of angiogenesis.Med Rev (2021). 2024 Jul 1;4(5):452-466. doi: 10.1515/mr-2023-0048. eCollection 2024 Oct. Med Rev (2021). 2024. PMID: 39444793 Free PMC article. Review.
-
Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration.Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):20. doi: 10.1167/iovs.65.12.20. Invest Ophthalmol Vis Sci. 2024. PMID: 39405051 Free PMC article. Review.
-
Complement regulation in the eye: implications for age-related macular degeneration.J Clin Invest. 2024 May 1;134(9):e178296. doi: 10.1172/JCI178296. J Clin Invest. 2024. PMID: 38690727 Free PMC article. Review.
-
Glycosaminoglycan microarrays for studying glycosaminoglycan-protein systems.Carbohydr Polym. 2024 Jul 1;335:122106. doi: 10.1016/j.carbpol.2024.122106. Epub 2024 Mar 29. Carbohydr Polym. 2024. PMID: 38616080 Review.
-
Bruch's Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration.J Clin Med. 2023 Apr 14;12(8):2870. doi: 10.3390/jcm12082870. J Clin Med. 2023. PMID: 37109207 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical